Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's prespective, June 19, 1995-FDA review process

Similar Items

• Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.
  Published: (1995)
• Drugs & biologics.
• FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.
  Published: (1988)
• FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988
  Published: (1988)
• FDA orange book : approved drug products with therapeutic equivalence evaluation (annual edition).